INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS
INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS
复制标题
DOI:
10.1172/jci114799
复制
发表时间:
1990-09-01
影响因子:
15.9
通讯作者:
DINARELLO, CA
中科院分区:
文献类型:
--
作者:
COMINELLI, F;NAST, CC;DINARELLO, CA
Interleukin 1 (IL-1) may be a key mediator of inflammation and tissue damage in inflammatory bowel disease (IBD). In rabbits with immune complex-induced colitis, IL-1.alpha. and .beta. mRNA levels were detectable at 4 h, peaked at 12 but were absent at 96 h after the induction of colitis. Colonic IL-1 tissue levels were measured by specific radioimmunoassays. IL-1.alpha. was significantly elevated at 4 h (9.4 .+-. 1.5 ng/g colon), progressively increased at 48 h (31 .+-. 5.8 ng/g) and then decreased by 96 h (11.5 .+-. 3.4 ng/g). IL-1.beta. levels were 2.0 .+-. 0.5 ng/g colon at 4 h, 5.0 .+-. 1.6 ng/g at 48 h and undetectable by 96 h. By comparison, colonic levels of PGE2 and LTB4 were unchanged during the first 12 h and did not become elevated until 24 h. IL-1.alpha. levels were highly correlated with inflammation (r = 0.885, P < 0.0001), edema (r = 0.789, P < 0.0001) and necrosis (r = 0.752, P < 0.0005). Treatment with a specific IL-1 receptor antagonist (IL-1ra) before and during the first 33 h after the administration of immune complexes markedly reduced inflammatory cell infiltration index (from 3.2 .+-. 0.4 to 1.4 .+-. 0.3, P < 0.02), edema (from 2.2 .+-. 0.4 to 0.6 .+-. 0.3, P < 0.01) and necrosis (from 43 .+-. 10% to 6.6 .+-. 3.2%, P < 0.03) compared to vehicle-matched colitis animals. These studies demonstrate that (a) IL-1 gene expression and synthesis occur early in the course of immune complex-induced colitis; (b) are significantly elevated for 12 h before the appearance of PGE2 and LTB4; (c) tissue levels of IL-1 correlate with the degree of tissue inflammation and; (3) specific blockade of IL-1 receptors reduces the inflammatory responses associated with experimental colitis.